MedPath

Podocon 25

Podocon-25® (25% podophyllin in benzoin tincture)

Approved
Approval ID

a13345b7-c42b-4459-b0ff-03cf91e46b7d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 17, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Podophyllum resin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-8699
Product Classification
G
Generic Name
Podophyllum resin
Product Specifications
Route of AdministrationTOPICAL
Effective DateFebruary 23, 2022
FDA Product Classification

INGREDIENTS (3)

PODOPHYLLUM RESINActive
Quantity: 1 mg in 4 mL
Code: 16902YVY2B
Classification: ACTIB
STYRAX BENZOIN RESINInactive
Code: FE663Z8IRO
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Podocon 25 - FDA Drug Approval Details